Literature DB >> 34192836

The paracaspase MALT1 in psoriasis.

Stephan Hailfinger1, Klaus Schulze-Osthoff2,3,4.   

Abstract

Psoriasis is a frequent autoimmune-related skin disease, which involves various cell types such as T cells, keratinocytes and dendritic cells. Genetic variations, such as mutations of CARD14, can promote the development of the disease. CARD14 mutations as well as the stimulation of immune and cytokine receptors activate the paracaspase MALT1, a potent activator of the transcription factors NF-κB and AP-1. The disease-promoting role of MALT1 for psoriasis is mediated by both its protease activity as well as its molecular scaffold function. Here, we review the importance of MALT1-mediated signaling and its therapeutic implications in psoriasis.
© 2021 Walter de Gruyter GmbH, Berlin/Boston.

Entities:  

Keywords:  BCL10; CARD14; CBM complex; NF-κB; paracaspase; protease

Mesh:

Substances:

Year:  2021        PMID: 34192836     DOI: 10.1515/hsz-2021-0250

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  4 in total

1.  Mucosa-associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors.

Authors:  Feng Wang; Gaozhan Liu; Lei Xiang; Jie Yuan; Ying Tao; Lin Zhang; Anbing Zhang; Xiuli Chang
Journal:  J Clin Lab Anal       Date:  2022-05-02       Impact factor: 3.124

2.  Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients.

Authors:  Zhigang Wu; Yingyan Bi
Journal:  J Clin Lab Anal       Date:  2022-01-08       Impact factor: 2.352

3.  MALT1 regulates Th2 and Th17 differentiation via NF-κB and JNK pathways, as well as correlates with disease activity and treatment outcome in rheumatoid arthritis.

Authors:  Qiubo Wang; Yapeng Wang; Qingyang Liu; Ying Chu; Rui Mi; Fengying Jiang; Jingjing Zhao; Kelong Hu; Ran Luo; Yufeng Feng; Harrison Lee; Dong Zhou; Jingyi Mi; Ruoyu Deng
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

4.  MALT1 serves as a biomarker for estimating disease risk of lupus nephritis: a prospective case-control study.

Authors:  Min Wang; Li Huang; Liping Peng; Yameng Yang; Jing Mao; Ning Zhu; Bin Wu
Journal:  Ann Transl Med       Date:  2022-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.